Related Experiment Video
Updated: Apr 19, 2026

A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
Vasculitis in children
Despina Eleftheriou1, Ezgi Deniz Batu2, Seza Ozen2
1Paediatric and Adolescent Rheumatology, UCL Institute of Child Health, London, UK.
Insights
Paediatric vasculitis, rare autoimmune diseases in children, require prompt diagnosis to prevent severe outcomes. Advances in research are improving classification, treatment trials, and management strategies for these young patients.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Rare Diseases
Background:
- Primary systemic vasculitides in the young are rare but serious conditions.
- Delayed diagnosis of childhood vasculitis leads to significant morbidity and mortality.
Purpose of the Study:
- To provide an overview of pediatric vasculitides.
- To highlight key differences in presentation and management between pediatric and adult vasculitis.
- To discuss advances and future directions in pediatric vasculitis research.
Main Methods:
- Literature review and synthesis of current research on pediatric vasculitis.
- Analysis of recent advancements in classification criteria and outcome measures.
- Examination of the inclusion of pediatric patients in clinical trials.
Main Results:
- Development of specific classification criteria and outcome tools for pediatric vasculitis.
- Increased inclusion of children in international, multicenter, randomized controlled trials.
- Adaptation of rare disease trial designs for pediatric vasculitis therapeutics.
Conclusions:
- Significant progress has been made in understanding and managing pediatric vasculitis.
- Unmet needs persist, necessitating further research into therapeutic avenues.
- Considerations for future clinical trial designs are crucial for advancing treatment options.
Abstract:
Primary systemic vasculitides of the young are relatively rare diseases, but are associated with significant morbidity and mortality, particularly if there is diagnostic delay. We provide an overview of paediatric vasculitides with emphasis on key differences in vasculitis presentation and management between children and adults. Significant advances in the field of paediatric vasculitis research include the development of classification criteria and disease outcome tools for paediatric disease; inclusion of paediatric patients in international multicentre randomized controlled trials of therapies in vasculitis; and development of rare disease trial designs for therapeutic trials of paediatric vasculitis. The continuation of unmet needs as well as the exploration of potential therapeutic avenues and considerations in the design of future trials are also discussed.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Vascular Spasm
Myocarditis III: Medical Management
Rheumatic Heart Disease I: Introduction
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests

